Skip to content
Screener

Chemed CHE Segment Vitas — Increase Decrease Medicare Cap Liability

Similar metrics at other companies

Eton Pharmaceuticals, Inc. logo
ETONIncrease Decrease In Accrued Medicaid Rebates
$1.82M-70.0%
G-III Apparel Group logo
GIIIIncrease Decrease In Refund Liability
$10.53M-47.8%
NovaGold Resources logo
NGIncrease Decrease In Remediation Liability
-$13K+76.4%
Plug Power logo
PLUGIncrease Decrease In Customer Liability
-$2.36M+89.1%
Innovative Solutions & Support logo
ISSCIncrease Decrease In Contract Liability
-$1.3M-448%
Consolidated Water Company logo
CWCOIncrease Decrease In Contract Liability
-$1.35M+58.9%

Other financials

Income statement

See full
Revenue$673.3M+8.8%
Gross profit$221.5M+19.9%
Operating income$89.2M+31.0%
Net income$67.7M+29.0%
EPS (diluted)$5.13+43.7%

Balance sheet

See full
Cash & equivalents$40.2M-83.9%
Total debt$181.3M+24.5%
Total equity$830.5M-30.7%
Total assets$1.6B-8.0%

Cash flow

See full
Operating cash flow$84.8M-38.8%
CapEx$15.5M-1.8%
Free cash flow$69.3M-43.6%

Valuation

See full
Market cap$7.18B+14.9%
Enterprise value$7.32B+19.1%
P/E26.1×+4.6×
P/S2.8×+0.3×

Profitability

See full
Gross margin33.1%-0.5pp
Operating margin13.5%-1.2pp
Net margin10.6%-1.0pp
FCF margin12.5%-2.3pp

Returns & leverage

See full
Return on equity27.1%+3.0pp
Debt / equity0.2×+0.1×
Current ratio0.9×-1.0×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept che:IncreaseDecreaseMedicareCapLiability.

The source filing: Chemed’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 9:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000019584-26-000012
Line itemMedicareMedicaidCommercialTotal
Continuous care16,5825511,00018,133
$398,108$15,432$11,609$425,149
All other revenue - self-pay, respite care, etc.5,578
Subtotal$430,727
Medicare cap adjustment(2,375)
Implicit price concessions(5,077)
Room and board, net(3,257)
Net revenue$420,018

Item 1. Financial Statements

FAQ

What is Chemed's segment vitas — increase decrease medicare cap liability?
Chemed (CHE) reported segment vitas — increase decrease medicare cap liability of -$2.38M in Q1 2026.
How has Chemed's segment vitas — increase decrease medicare cap liability changed year-over-year?
Chemed's segment vitas — increase decrease medicare cap liability decreased by 2.2% year-over-year, from -$2.33M to -$2.38M.
What is the long-term trend for Chemed's segment vitas — increase decrease medicare cap liability?
Over 3 years (2021 to 2025), Chemed's segment vitas — increase decrease medicare cap liability has grown at a 60.4% compound annual growth rate (CAGR), from $6.6M to $27.2M.
What does segment vitas — increase decrease medicare cap liability mean?
Reflects the periodic adjustment to the liability account representing potential repayments to Medicare for exceeding statutory reimbursement caps. Changes in this balance indicate potential regulatory risk or shifts in service delivery patterns.

Ask your AI about Chemed's segment vitas — increase decrease medicare cap liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude